Universal-Beteiligungs- und Servicegesellschaft
BCRX icon

Universal-Beteiligungs- und Servicegesellschaft’s BioCryst Pharmaceuticals BCRX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$318K Buy
31,820
+2,489
+8% +$22.5K ﹤0.01% 1915
2026
Q1 		$279K Sell
29,331
-2,460
-8% -$19.1K ﹤0.01% 1886
2025
Q4 		$248K Sell
31,791
-9,378
-23% -$67.8K ﹤0.01% 1921
2025
Q3 		$312K Buy
41,169
+23,177
+129% +$193K ﹤0.01% 1888
2025
Q2 		$161K Buy
17,992
+1,288
+8% +$12K ﹤0.01% 1957
2025
Q1 		$125K Buy
+16,704
New +$135K ﹤0.01% 1933

Other funds holding BCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's BCRX Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its BioCryst Pharmaceuticals (BCRX) stake by 8.5% in Q2 2026, buying an estimated $22.5K and bringing the position to 31,820 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #1915.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in BCRX in Q1 2025 and has held it in 6 quarters since. 318 funds tracked by Wall St. Rank hold BCRX as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 31,820 shares of BioCryst Pharmaceuticals worth $318K as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 2,489 BioCryst Pharmaceuticals shares in Q2 2026, an estimated $22.5K.
  • BioCryst Pharmaceuticals made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1915 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in BioCryst Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 318 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.